Nonlymphoma hematological malignancies in systemic lupus erythematosus

Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis

“…There were 37 studies with overlapping populations. Sixteen studies reported data included in the International lupus cohort [12,[24][25][26][27][28][29][30][31][32][33][34][35][36][37][38], and there were data overlaps from two studies in Denmark [39,40], two from Finland [41,42], 12 from Sweden [43][44][45][46][47][48][49][50][51][52][53][54], and five from Taiwan [55][56][57][58][59].…”

“…When considering meta-analyses for the 40 malignancies, five of 51 studies [28,29,33,60,61] were excluded from analyses because they could not be pooled or had overlapping populations. Overlapping populations were considered on a malignancy outcome level.…”

Changes in the autoantibody pattern during allogeneic stem-cell transplantation for acute myeloid leukemia complicated by systemic lupus erythematosus

“…Non-Hodgkin's lymphomas are the most frequent hematological malignancies in patients with SLE, but AML is rare. 15 AML is a very rare complication in patients with APS. 16 However, it is clear that further studies on such complicated situations in clinical practice are required because the incidence of comorbidity is expected to increase based on improvements in the survival ratio of SLE as well as the increased leukemia risk in patients with SLE.…”